BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15878827)

  • 1. Expression, purification, and functional testing of recombinant CYR61/CCN1.
    Schütze N; Kunzi-Rapp K; Wagemanns R; Nöth U; Jatzke S; Jakob F
    Protein Expr Purif; 2005 Jul; 42(1):219-25. PubMed ID: 15878827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
    Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
    Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells.
    Schütze N; Schenk R; Fiedler J; Mattes T; Jakob F; Brenner RE
    BMC Cell Biol; 2007 Oct; 8():45. PubMed ID: 17973995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYR61 (CCN1) is essential for placental development and vascular integrity.
    Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
    Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix protein CCN1 (CYR61) promotes proliferation, migration and tube formation of endothelial progenitor cells.
    Yu Y; Gao Y; Wang H; Huang L; Qin J; Guo R; Song M; Yu S; Chen J; Cui B; Gao P
    Exp Cell Res; 2008 Oct; 314(17):3198-208. PubMed ID: 18755182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.
    Han JS; Macarak E; Rosenbloom J; Chung KC; Chaqour B
    Eur J Biochem; 2003 Aug; 270(16):3408-21. PubMed ID: 12899698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
    Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
    Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.
    Chen N; Leu SJ; Todorovic V; Lam SC; Lau LF
    J Biol Chem; 2004 Oct; 279(42):44166-76. PubMed ID: 15308622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.
    Athanasopoulos AN; Schneider D; Keiper T; Alt V; Pendurthi UR; Liegibel UM; Sommer U; Nawroth PP; Kasperk C; Chavakis T
    J Biol Chem; 2007 Sep; 282(37):26746-26753. PubMed ID: 17626014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).
    Leu SJ; Liu Y; Chen N; Chen CC; Lam SC; Lau LF
    J Biol Chem; 2003 Sep; 278(36):33801-8. PubMed ID: 12826661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
    Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
    Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
    Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
    Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
    Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional properties and intracellular signaling of CCN1/Cyr61.
    Chen Y; Du XY
    J Cell Biochem; 2007 Apr; 100(6):1337-45. PubMed ID: 17171641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration.
    Grote K; Salguero G; Ballmaier M; Dangers M; Drexler H; Schieffer B
    Blood; 2007 Aug; 110(3):877-85. PubMed ID: 17429007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
    Xu XL; Liu GF; Huang DY
    Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.
    Kireeva ML; MO FE; Yang GP; Lau LF
    Mol Cell Biol; 1996 Apr; 16(4):1326-34. PubMed ID: 8657105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immediate early gene product hCYR61 localizes to the secretory pathway in human osteoblasts.
    Lechner A; Schütze N; Siggelkow H; Seufert J; Jakob F
    Bone; 2000 Jul; 27(1):53-60. PubMed ID: 10865209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells.
    Kolesnikova TV; Lau LF
    Oncogene; 1998 Feb; 16(6):747-54. PubMed ID: 9488038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.